Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ZK International (ZKIN) Other Accumulated Expenses (2022 - 2025)

ZK International (ZKIN) has disclosed Other Accumulated Expenses for 4 consecutive years, with $13064.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 93.98% to $13064.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $13064.0, a 93.98% decrease, with the full-year FY2025 number at $13064.0, down 93.98% from a year prior.
  • Other Accumulated Expenses was $13064.0 for Q3 2025 at ZK International, down from $216906.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $2.1 million in Q3 2022 to a low of $13064.0 in Q3 2025.
  • A 4-year average of $848343.5 and a median of $663953.5 in 2023 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: crashed 45.87% in 2023, then crashed 93.98% in 2025.
  • ZK International's Other Accumulated Expenses stood at $2.1 million in 2022, then plummeted by 45.87% to $1.1 million in 2023, then plummeted by 80.48% to $216906.0 in 2024, then plummeted by 93.98% to $13064.0 in 2025.
  • Per Business Quant, the three most recent readings for ZKIN's Other Accumulated Expenses are $13064.0 (Q3 2025), $216906.0 (Q3 2024), and $1.1 million (Q3 2023).